Clinical Trial Update: A Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0215-0384 Administered to Subjects With Moderate to Severe Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the safety, tolerability, pharmacokinetics and pharmacodynamics of NNC0215-0384 in adults with moderate to severe rheumatoid arthri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• NNC0215-0384

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Inflammation, Rheumatoid Arthritis | Phase 1 | Status: COMPLETED